respiratory distress syndrome, transient tachypnea of the newborn, surfactant administration, NICU admission, hospital length of stay, 5-minute Apgar score < 7 and birthweight. The primary analysis compared all eligible women in each cohort; a sensitivity analysis compared preprotocol outcomes to those of postprotocol neonates who received antenatal steroids. Multivariable linear and logistic regression analyses were performed. RESULTS: Of 125 eligible mother-neonate pairs, 52.8% (N¼66) were in postprotocol period and 75.6% of those (N¼50) received steroids (mean gestational age: 34.6 AE 2.4 weeks). There was no significant difference between the demographic of the cohorts. After controlling for gestational age at delivery, neonates in the postprotocol period had an increased odds of hypoglycemia <60 mg/dL (aOR 3.17, 95% 1.40-7.21). No secondary outcomes significantly differed between groups (Table) . In the sensitivity analysis, odds of both hypoglycemia 60 mg/dL (aOR 2.82; 95% CI 1.19-6.72) and 40 mg/dL (aOR 2.49; 95% CI 1.13-5.52) were significantly greater in the postprotocol neonates who received steroids compared to preprotocol cohort. CONCLUSION: After implementation of an antenatal late preterm steroid protocol, the majority of pregnant women with DM who were admitted in the late preterm period received steroids. Neonates born following protocol implementation experienced an increased frequency of hypoglycemia.
Pregnancy outcomes associated with implementation of early diabetes screening guidelines
Nevert Badreldin, Rebecca Weiss, Kathleen Drexler, Lynn Yee
Northwestern University Feinberg School of Medicine, Chicago, IL OBJECTIVE: To evaluate uptake of the 2013 ACOG guideline on early screening for diabetes mellitus during pregnancy and to assess pregnancy outcomes before and after changes in screening guideline. STUDY DESIGN: Retrospective cohort study of women with singleton gestations who received prenatal care between 8/2012-2013 ("preguideline") and 4/2014-2015 ("post-guideline") . Women with pregestational diabetes (before screening) or late entry to prenatal care (! 21w) were excluded. Demographic characteristics and pregnancy outcomes were abstracted from prenatal and inpatient records. Pregnancy outcomes of interest included gestational age at delivery, gestational weight gain, diagnosis of gestational diabetes mellitus (GDM), cesarean delivery, postpartum hemorrhage (PPH), and birthweight. Screening frequency in accordance with the guideline was assessed, and pregnancy outcomes before and after the guideline were compared using bivariable and multivariable analysis. A subgroup analysis was conducted comparing the pre-guideline cohort to only women in the post-guideline cohort who were appropriately screened. RESULTS: Of 2,069 women eligible for analysis, 64.6% (N¼1,337) were in the post-guideline cohort. Cohorts were similar in terms of parity, BMI, insurance, and first trimester entry to prenatal care, but the post-guideline cohort was older (p¼0.012), more likely to have a history of smoking (p¼0.001), and more likely to be non-Hispanic white (p¼0.001). Adherence to the ACOG screening guideline was significantly lower in the post-guideline cohort (32.8% vs. 57.9%, p<0.001). On multivariable analysis, the post-guideline cohort had similar frequencies of term delivery, Apgar score < 7, and PPH, but a significantly lower frequency of GDM diagnosis and lower gestational weight gain (Table) . Subgroup analysis showed significantly less weight gain during pregnancy in the appropriately screened post-guideline cohort (ab-3.72, -6.74 to -0.91). CONCLUSION: Introduction of ACOG early diabetes screening guideline did not improve screening rates. Significantly lower rates of diagnosed GDM in the post-guidelines cohort suggests that poor screening compliance may result in decreased detection of GDM.
356 The impact of antepartum hospitalization on maternal psychological well-being
Nicole L. MacCleary Price
Cleaveland Clinic Akron General, Akron, OH OBJECTIVE: The primary objective of this study was to identify trends in maternal anxiety and/or depression based on the duration and/or frequency of antenatal hospitalization(s). STUDY DESIGN: This was a prospective cohort study design involving women of all racial and ethnic backgrounds admitted to the antepartum unit of a tertiary care obstetric center between December 1, 2016 and November 30, 2017. Anxiety and depression were measured using the PHQ-9 and the HADS on admission and every seven days thereafter until delivery or discharge. Patients with repeated admissions were asked to complete the questionnaires on Poster Session II 
